Early positive data reported for geographic atrophy modifier gene therapy
Key takeaways: Low-dose OCU410 slowed lesion growth, preserved retinal tissue, and stabilized visual function in three patients. No drug-related serious adverse events were reported. OCU410, a single-dose modifier gene therapy,…